Skip to main content
. 2013 Nov 28;19(44):8114–8132. doi: 10.3748/wjg.v19.i44.8114

Table 2.

Quality assessment scoring of included studies, according to NOS criterion

Author, year Selection Comparability1 Outcome assessment Star Score
1 2 3 4 5 6 7
Dulucq et al[28], 2005 * * * * * * ******
Usui et al[9], 2005 * * * * * *****
Kim et al[34], 2008 * * * * ****
Mochiki et al[15], 2008 * * * * * * ******
Topal et al[14], 2008 * * * ** ** * ********
Kawamura et al[30], 2009 * * * ** * * * ********
Sakuramoto et al[16], 2009 * * * ** * * *******
Du et al[27], 2010 * * * ** * * *******
Kim et al[33], 2011 * * * ** * * *******
Eom et al[10], 2012 * * * * * *****
Guan et al[17], 2012 * * * * * *****
Siani et al[38], 2012 * * * * * * * *******
Kim et al[32], 2013 * * * ** * ******
Jeong et al[29], 2013 * * * ** * * *******
Lee et al[37], 2013 * * * ** * * * ********

Based on Newcastle-Ottowa Scale with maximum of *** for selection, ****for comparability, and ** for outcome assessment.

1

Comparability variables are (1) age, (2) sex, (3) body mass index, (4) American Society of Anesthesiologists, (5) comorbidity, (6) tumor size and (7) tumor stage. Group comparable for (1)-(3) or (4)-(7) (if yes, two stars, one star if one of these three characteristics was not reported, even if there were no other differences between the two groups and other characteristics had been controlled; no points were assigned if the two groups differed).